Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics società ha sostenuto
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leggi di più
Excellent medical, dental, and vision coverage.
Che cosa ti rende più felice sul posto di lavoro?
Celebrating success achieved as a team.
Quali sono alcune delle cose migliori della tuo team?
We all work hard together to meet deadlines and help patients.
Cosa ti piace di più del team di leadership?
The leadership team is connected to everyone, not isolated in a board room.
Other Employee Reviews for Karyopharm Therapeutics
×